EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Outcome and Safety of Insulin in the Management of Smell Loss: A Systematic Review

Thamer M AlBilasi, Rawan Mahmoud Alanazi, Lama F AlDhawi iD, Abeer Ali Albathi

Ear, Nose & Throat Journal · 2023

DOI: 10.1177/01455613231201028 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Ear, Nose & Throat Journal, 2023. Verfasst von Thamer M AlBilasi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head & Neck Surgery (ORL-H&N), Prince Sultan Military Medical City (PSMMC), Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Insulin, COVID-19, Anosmia, Olfaction Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Olfactory dysfunction can negatively impact the quality of life and increase the risk of danger from warning odors. Various factors can cause olfactory dysfunction, including COVID-19 infection, which has increased anosmia cases. No medications are approved; however, recent studies have suggested that intranasal insulin could effectively treat olfactory dysfunction.

Aim

To comprehensively evaluate the effectiveness and safety of intranasal insulin in treating olfactory dysfunction. Materials and Methods: PubMed, Google Scholar, and CENTRAL databases were searched using specific keywords, and the outputs were screened using the Rayyan AI system. Original research articles published without time frame limitations that reported the relevant outcomes were included. The reviewers performed the screening and data extraction, and any disagreements were resolved by a third senior author.

Results

This systematic review identified 66 references from 3 databases, with 45 articles meeting the criteria for review after duplicates were removed. Six articles met the inclusion criteria and were selected, including 177 subjects. The selected studies consisted of various study designs, including pilot studies, placebo-controlled trials, crossover studies, and randomized clinical trials. The findings showed that intranasal insulin therapy had beneficial effects on olfactory function. Specifically, improvements were observed in olfactory detection and discrimination in patients with post-COVID-19 anosmia, olfactory threshold performance in healthy participants, and odor identification in hyposmic patients. However, there were variations in the observed effects based on different doses of insulin administered and gender differences. It also shows that using insulin provides good outcomes. Using it intranasally was safe and did not cause any complications.

Conclusion

Intranasal insulin has shown promising results as a potentially safe treatment for olfactory dysfunction. Studies suggest that it can improve olfactory thresholds. Further studies are needed to investigate optimal doses and potential gender differences in response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinCOVID-19AnosmiaOlfaction DisordersHumansAdministration, IntranasalTreatment OutcomeSARS-CoV-2MaleFemale

Stichwörter der Autor:innen

COVID-19 infectionanosmiahyposmiaintranasal insulinolfactory dysfunction

Substanzen

Insulin

Autor:innen und Institutionen

  • Department of Otolaryngology - Head & Neck Surgery (ORL-H&N), Prince Sultan Military Medical City (PSMMC), Riyadh, Saudi Arabia.
  • A Medical Student College of Medicine, Dar Al Uloom University, Riyadh, Saudi Arabia.
  • A Medical Student at Al-Maarefa University College of Medicine, Riyadh, Saudi Arabia.

ORCID-Profile: Lama F AlDhawi

Zitieren

APA

AlBilasi, T. M., Alanazi, R. M., AlDhawi, L. F., & Albathi, A. A. (2023). Outcome and Safety of Insulin in the Management of Smell Loss: A Systematic Review. Ear, Nose & Throat Journal. https://doi.org/10.1177/01455613231201028

Vancouver

AlBilasi TM, Alanazi RM, AlDhawi LF, Albathi AA. Outcome and Safety of Insulin in the Management of Smell Loss: A Systematic Review. Ear, Nose & Throat Journal. 2023. doi:10.1177/01455613231201028

BibTeX
@article{AlBilasi2023,
  author = {AlBilasi, Thamer M and Alanazi, Rawan Mahmoud and AlDhawi, Lama F and Albathi, Abeer Ali},
  title = {Outcome and Safety of Insulin in the Management of Smell Loss: A Systematic Review},
  journal = {Ear, Nose & Throat Journal},
  year = {2023},
  doi = {10.1177/01455613231201028}
}
Kostenlos starten →